Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases

NCT05996731 is registered in ClinicalTrials.gov with Mario Negri Institute for Pharmacological Research as lead sponsor.

NCT NCT05996731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05996731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
Lead sponsor
Mario Negri Institute for Pharmacological Research
Phase
Not applicable
Overall status
Recruiting
Start date
February 21, 2024
Completion date
June 30, 2026
Enrollment
105 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical hemolytic uremic syndrome, autosomal dominant polycystic kidney, healthy, membranoproliferative glomerulonephritis